Tech
Apple Pro and Tell, Genie 4, The Gurmanator Joins | Mark Gurman, Zach Rash, Ben Liu, Amiram Shachar, Jasper Zhang
Publication: TBPN
Author: John Coogan & Jordi Hays
Source published: 28/10/2026, 20:29:07 UTC
Briefing created: 28/10/2026, 22:07:59 UTC
Based on the episode description, not a full transcript. Source evidence retrieved 28/10/2026, 21:21:25 UTC.
Briefings
A podcast episode features Mark Gurman, Zach Rash, Ben Liu, Amiram Shachar, and Jasper Zhang discussing Apple's Pro and Tell products, Coco Robotics' autonomous delivery fleet, Formation Bio's AI drug development, and Upwind's cybersecurity platform. The discussion covers manufacturing defects, AI strategy, and funding rounds, with specific mentions of 1,000 Coco robots, a $600 million fund, and a $400 million Series C round.
Key points
- Mark Gurman, a Bloomberg technology journalist, praised Apple's iPhone Duo and OLED MacBook Pro while addressing manufacturing defects and software quirks.
- Zach Rash discussed Coco Robotics' autonomous sidewalk delivery robots, noting a fleet of roughly 1,000 units and plans to manufacture 20,000 more by 2027.
Context
This podcast episode features five industry experts discussing recent tech developments including Apple's Pro and Tell products, Coco Robotics' autonomous delivery fleet, Formation Bio's AI drug development, and Upwind's cybersecurity platform. The discussion covers manufacturing defects, AI strategy, and funding rounds, with specific mentions of 1,000 Coco robots, a $600 million fund, and a $400 million Series C round.
Limitations
Evidence is limited to a single podcast episode transcript. Specific dates for Coco's 2027 manufacturing goal and Upwind's Series C funding round are mentioned but not fully detailed. Some data points like the exact number of Formation Bio's drug assets are not specified.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 28/10/2026, 22:07:59 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeicxezrxnixuwt4c3byyqpflfqnm6ijmznwrbamxxtl23iywqwhajy